Endocrine Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 23.9 | Q1 | 98.0% | 9.991 | Q1 | 99.7% |
| 2024 | 22.0 | Q1 | 98.4% | 9.175 | Q1 | 99.7% |
| 2023 | 22.0 | Q1 | 97.7% | 7.922 | Q1 | 99.6% |
| 2022 | 20.3 | Q1 | 96.8% | 7.205 | Q1 | 99.6% |
| 2021 | 25.3 | Q1 | 97.5% | 6.860 | Q1 | 99.5% |
| 2020 | — | — | 6.357 | Q1 | 99.4% | |
| 2019 | — | — | 4.991 | Q1 | 99.1% | |
| 2018 | — | — | 6.257 | Q1 | 99.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0163-769X
ISSN
1945-7189
country
UScoverage
1980-2026